{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:26:18Z","timestamp":1792146378098,"version":"4.4.0"},"reference-count":57,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2069,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1478-3231.2009.02126.x","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T13:25:46Z","timestamp":1254144346000},"page":"102-111","source":"Crossref","is-referenced-by-count":20,"title":["Hepatic progenitor cells in liver cancers from Asian children"],"prefix":"10.1111","volume":"30","author":[{"given":"Stephen C.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swan N.","family":"Thung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat Hon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Khang Bui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Le","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja June","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB1","doi-asserted-by":"crossref","unstructured":"1.\u00e2\u0080\u0082 Meyers RL. Tumors of the liver in children. Surg Oncol 2007; 16: 195\u00e2\u0080\u0093203.","DOI":"10.1016\/j.suronc.2007.07.002"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB2","first-page":"333","volume-title":"Pathology of neoplasia in children and adolescents","author":"Weinberg","year":"1986"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u00e2\u0080\u0082 Isaacs H Jr Fetal and neonatal hepatic tumors. J Pediatr Surg 2007; 42: 1797\u00e2\u0080\u0093803.","DOI":"10.1016\/j.jpedsurg.2007.07.047"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u00e2\u0080\u0082 Spector LG , Johnson KJ , Soler JT , Puumala SE . Perinatal risk factors for hepatoblastoma. Br J Cancer 2008; 98: 1570\u00e2\u0080\u00933.","DOI":"10.1038\/sj.bjc.6604335"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB5","doi-asserted-by":"crossref","unstructured":"5.\u00e2\u0080\u0082 Davies JQ , de la Hall PM , Kaschula RO , et al. Hepatoblastoma-evolution of management, outcome and significance of histology of the resected tumor. A 30-year experience with 41 cases. J Pediatr Surg 2004; 39: 1321\u00e2\u0080\u00937.","DOI":"10.1016\/j.jpedsurg.2004.05.020"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u00e2\u0080\u0082 Finegold MJ , Egler RA , Goss JA , et al. Liver tumors: pediatric population. Liver Transpl 2008; 14: 1545\u00e2\u0080\u009356.","DOI":"10.1002\/lt.21654"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u00e2\u0080\u0082 Schnater JM , Aronson DC , Plaschkes J , et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 94: 1111\u00e2\u0080\u009320.","DOI":"10.1002\/cncr.10282"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB8","unstructured":"8.\u00e2\u0080\u0082 Jaskiewicz K , Banach L , Izycka E. Hepatocellular carcinoma in young patients: histology, cellular differentiation, HBV infection and oncoprotein p53. Anticancer Res 1995; 15: 2723\u00e2\u0080\u00935."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u00e2\u0080\u0082 Bosch FX , Ribes J , Borras J. Epidemiology of primary liver cancer. Semin Liv Dis 1999; 19: 271\u00e2\u0080\u009385.","DOI":"10.1055\/s-2007-1007117"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB10","doi-asserted-by":"crossref","unstructured":"10.\u00e2\u0080\u0082 Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002; 181182: 35\u00e2\u0080\u00938.","DOI":"10.1016\/S0300-483X(02)00251-2"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u00e2\u0080\u0082 Moore SW , Davidson A , Hadley GP , et al. Malignant liver tumors in South African children: a national audit. World J Surg 2008; 32: 1389\u00e2\u0080\u009395.","DOI":"10.1007\/s00268-008-9526-8"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB12","first-page":"159","volume-title":"Tumors of the Liver and Intrahepatic Bile Ducts","author":"Ishak","year":"2001"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u00e2\u0080\u0082 Roskams T , Vos RD , Eyken PV , et al. Hepatic OV-6 expression in human liver disease and rat experiments evidence for hepatic progenitor cells in man. J Hepatol 1998; 29: 455\u00e2\u0080\u009363.","DOI":"10.1016\/S0168-8278(98)80065-2"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u00e2\u0080\u0082 Sell S , Leffert HL. Liver cancer stem cells. J Clin Oncol 2008; 26: 2800\u00e2\u0080\u00935.","DOI":"10.1200\/JCO.2007.15.5945"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u00e2\u0080\u0082 Theise ND , Yao JL , Harada K , et al. Hepatic \u00e2\u0080\u009cstem cell\u00e2\u0080\u009d malignancies in adults: four cases. Histopathology 2003; 43: 263\u00e2\u0080\u009371.","DOI":"10.1046\/j.1365-2559.2003.01707.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u00e2\u0080\u0082 Komuta M , Spee B , Van der Borght S , et al. Clinicopathological study on cholangiocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008; 47: 1544\u00e2\u0080\u009356.","DOI":"10.1002\/hep.22238"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB17","doi-asserted-by":"crossref","unstructured":"17.\u00e2\u0080\u0082 Theise ND , Saxena R , Portmann BC , et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999; 30: 1425\u00e2\u0080\u009333.","DOI":"10.1002\/hep.510300614"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB18","doi-asserted-by":"crossref","unstructured":"18.\u00e2\u0080\u0082 Kim JW , Ye Q , Forgues M , et al. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004; 39: 518\u00e2\u0080\u009327.","DOI":"10.1002\/hep.20053"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u00e2\u0080\u0082 Ma S , Chan KW , Hu L , et al. Identification and characterization of tumorigenic liver cancer stem\/progenitor cells. Gastroenterology 2007; 132: 2542\u00e2\u0080\u009356.","DOI":"10.1053\/j.gastro.2007.04.025"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u00e2\u0080\u0082 Mao L , Qiu YD , Fang S , et al. Liver progenitor cells activated after 30% small-for-size liver transplantation in rats: a preliminary study. Transplant Proc 2008; 40: 1635\u00e2\u0080\u009340.","DOI":"10.1016\/j.transproceed.2008.03.133"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB21","doi-asserted-by":"crossref","unstructured":"21.\u00e2\u0080\u0082 Durnez A , Verslype C , Nevens F , et al. The clinicopathological and prognostic relevance of cytokeratin7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006; 49: 138\u00e2\u0080\u009351.","DOI":"10.1111\/j.1365-2559.2006.02468.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB22","doi-asserted-by":"crossref","unstructured":"22.\u00e2\u0080\u0082 Yang XR , Xu Y , Shi GM , et al. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in HCC patients after curative resection. Clin Cancer Res 2008; 14: 3850\u00e2\u0080\u00939.","DOI":"10.1158\/1078-0432.CCR-07-4338"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB23","doi-asserted-by":"crossref","unstructured":"23.\u00e2\u0080\u0082 Zhuang PY , Zhang JB , Zhu XD , et al. Two pathologic types of hepatocellular carcinoma with lymphnode metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 2008; 112: 2740\u00e2\u0080\u00938.","DOI":"10.1002\/cncr.23488"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB24","doi-asserted-by":"crossref","unstructured":"24.\u00e2\u0080\u0082 Trzpis M , McLaughlin PMJ , de Leij LMFH , Harmsen MC . Epithelial cell adhesion molecule. More than a carcinoma marker and adhesion molecule. Am J Pathol 2007; 171: 386\u00e2\u0080\u009395.","DOI":"10.2353\/ajpath.2007.070152"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u00e2\u0080\u0082 Yamashita T , Forgues M , Wang W , et al. EpCAM and alpha-fetoprotein expression defines novel prognostic types of HCC. Cancer Res 2008; 68: 1451\u00e2\u0080\u009361.","DOI":"10.1158\/0008-5472.CAN-07-6013"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB26","doi-asserted-by":"crossref","unstructured":"26.\u00e2\u0080\u0082 Ruck P , Xiao JC , Pietsch T , Kaiserling E. Hepatic stem cells in the human liver. Histopathology 1996; 29: 590\u00e2\u0080\u00932.","DOI":"10.1046\/j.1365-2559.1996.d01-547.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB27","doi-asserted-by":"crossref","unstructured":"27.\u00e2\u0080\u0082 Ruck P , Xiao JC , Pietsch T , Von Schweinitz D , Kaiserling E. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology 1997; 31: 324\u00e2\u0080\u00939.","DOI":"10.1046\/j.1365-2559.1997.2750870.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB28","doi-asserted-by":"crossref","unstructured":"28.\u00e2\u0080\u0082 Ruck P , Wichert G , Handgretinger R , Kaiserling E. Ep-CAM in malignant liver tumours. J Pathol 2000; 191: 102\u00e2\u0080\u00933.","DOI":"10.1002\/(SICI)1096-9896(200005)191:1<102::AID-PATH542>3.0.CO;2-X"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB29","doi-asserted-by":"crossref","unstructured":"29.\u00e2\u0080\u0082 Badve S , Logdberg L , Lal A , et al. Small cells in hepatoblastoma lack \u00e2\u0080\u009coval\u00e2\u0080\u009d cell phenotype. Mod Pathol 2003; 16: 930\u00e2\u0080\u00936.","DOI":"10.1097\/01.MP.0000086486.52370.81"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB30","doi-asserted-by":"crossref","unstructured":"30.\u00e2\u0080\u0082 Fiegel HC , Gl\u00c3\u00bcer S , Roth B , et al. Stem-like cells in human hepatoblastoma. J Histochem Cytochem 2004; 52: 1495\u00e2\u0080\u0093501.","DOI":"10.1369\/jhc.4A6297.2004"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB31","doi-asserted-by":"crossref","unstructured":"31.\u00e2\u0080\u0082 Nguyen VT , Law MG , Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int 2008; 28: 525\u00e2\u0080\u009331.","DOI":"10.1111\/j.1478-3231.2007.01646.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB32","doi-asserted-by":"crossref","unstructured":"32.\u00e2\u0080\u0082 Lee DH , Kim JH , Nam JJ , Kim HR , Shin HR . Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002; 17: 457\u00e2\u0080\u009362.","DOI":"10.3346\/jkms.2002.17.4.457"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB33","doi-asserted-by":"crossref","unstructured":"33.\u00e2\u0080\u0082 Finegold MJ. Tumors of the Liver. Semin Liver Dis 1994; 14: 270\u00e2\u0080\u009381.","DOI":"10.1055\/s-2007-1007317"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB34","doi-asserted-by":"crossref","unstructured":"34.\u00e2\u0080\u0082 Abe K , Edamoto Y , Park YN , et al. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998; 28: 568\u00e2\u0080\u009372.","DOI":"10.1002\/hep.510280239"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB35","doi-asserted-by":"crossref","unstructured":"35.\u00e2\u0080\u0082 Ishimura M , Ohga S , Nagatoshi Y , et al. Malignant hepatic tumor occurring 10 years after a histocompatible sibling donor bone marrow transplantation for severe apalastic anemia. Pediatr Transpl 2007; 11: 945\u00e2\u0080\u00939.","DOI":"10.1111\/j.1399-3046.2007.00802.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB36","doi-asserted-by":"crossref","unstructured":"36.\u00e2\u0080\u0082 Inagaki M , Yagi T , Urushihara N , et al. Successfully resected hepatoblastoma in a young adult with chronic hepatitis B: report of a case. Eur J Gastroenterol Hepatol 2001; 13: 981\u00e2\u0080\u00934.","DOI":"10.1097\/00042737-200108000-00020"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB37","unstructured":"37.\u00e2\u0080\u0082 Gerber MA , Thung SN , Shen S , et al. Phenotypic characterization of hepatic proliferation: antigen expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol 1983; 110: 70\u00e2\u0080\u00934."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB38","unstructured":"38.\u00e2\u0080\u0082 Sell S , Dunsford H. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134: 1347\u00e2\u0080\u009363."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB39","doi-asserted-by":"crossref","unstructured":"39.\u00e2\u0080\u0082 Farber E. Ethionine carcinogenesis. Adv Cancer Res 1963; 7: 383\u00e2\u0080\u0093474.","DOI":"10.1016\/S0065-230X(08)60986-0"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB40","doi-asserted-by":"crossref","unstructured":"40.\u00e2\u0080\u0082 Roskams TA , Theise ND , Balabaud C , et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39: 1739\u00e2\u0080\u009345.","DOI":"10.1002\/hep.20130"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB41","unstructured":"41.\u00e2\u0080\u0082 Haque S , Haruna Y , Nalesnik MA , et al. Identification of bipotential progenitor cells in human liver regeneration. Lab Invest 1996; 75: 699\u00e2\u0080\u0093705."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB42","doi-asserted-by":"crossref","unstructured":"42.\u00e2\u0080\u0082 Robrechts C , De Vos R , Van den Heuvel M , et al. Primary liver tumours of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver 1998; 18: 288\u00e2\u0080\u009393.","DOI":"10.1111\/j.1600-0676.1998.tb00168.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB43","doi-asserted-by":"crossref","unstructured":"43.\u00e2\u0080\u0082 Lee JS , Heo J , Libbrecht L , et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12: 410\u00e2\u0080\u00936.","DOI":"10.1038\/nm1377"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB44","unstructured":"44.\u00e2\u0080\u0082 Villanueva A , Newell P , Chiang DY , et al. Molecular and clinical characterization of hepatocellular carcinoma with progenitor cell markers. 59th Annual Meeting of the American Association for the Study of Liver Diseases; 2008 October 31\u00e2\u0080\u0093November 4; San Francisco, CA. Alexandria (VA): American Association for the Study of Liver Diseases; 2008. Hepatology 48 (Suppl.), 361A\u00e2\u0080\u00932A."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB45","doi-asserted-by":"crossref","unstructured":"45.\u00e2\u0080\u0082 Prokurat A , Kluge P , Kosciesza A , et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 2002; 39: 510\u00e2\u0080\u00938.","DOI":"10.1002\/mpo.10177"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB46","doi-asserted-by":"crossref","unstructured":"46.\u00e2\u0080\u0082 Becker G , Schmitt-Graeff A , Ertelt V , et al. CD117 (c-kit) expression in human hepatocellular carcinoma. Clin Oncol (R Coll Radiol) 2007; 19: 204\u00e2\u0080\u00938.","DOI":"10.1016\/j.clon.2006.12.009"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB47","unstructured":"47.\u00e2\u0080\u0082 Hanabata M , Ohyanagi H , Saitoh Y , Itoh H. Immunohistochemical study on hepatic tumors \u00e2\u0080\u0093 KM01 stains compared with AFP, CEA, CA19-9 and RAS P21. Kobe J Med Sci 1991; 37: 81\u00e2\u0080\u009396."},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB48","doi-asserted-by":"crossref","unstructured":"48.\u00e2\u0080\u0082 Tsuji M , Kashihara T , Terada N , Mori H. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19. Pathol Int 1999; 49: 310\u00e2\u0080\u00937.","DOI":"10.1046\/j.1440-1827.1999.00865.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB49","doi-asserted-by":"crossref","unstructured":"49.\u00e2\u0080\u0082 Ng IO , Lai EC , Chan AS , So MK. Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation. J Gastroenterol Hepatol 1995; 10: 250\u00e2\u0080\u00935.","DOI":"10.1111\/j.1440-1746.1995.tb01089.x"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB50","doi-asserted-by":"crossref","unstructured":"50.\u00e2\u0080\u0082 Saegusa M , Takano Y , Kishimoto H , et al. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas\u00e2\u0080\u0093an enhanced immunohistochemical approach. J Cancer Res Clin Oncol 1993; 119: 737\u00e2\u0080\u009344.","DOI":"10.1007\/BF01195346"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB51","doi-asserted-by":"crossref","unstructured":"51.\u00e2\u0080\u0082 Wee A , Teh M , Raju GC. p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection. J Clin Pathol 1995; 48: 236\u00e2\u0080\u00938.","DOI":"10.1136\/jcp.48.3.236"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB52","doi-asserted-by":"crossref","unstructured":"52.\u00e2\u0080\u0082 Chen TC , Hsieh LL , Kuo TT. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma. J Pathol 1995; 176: 243\u00e2\u0080\u00937.","DOI":"10.1002\/path.1711760306"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB53","doi-asserted-by":"crossref","unstructured":"53.\u00e2\u0080\u0082 de La Coste A , Romagnolo B , Billuart P , et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95: 8847\u00e2\u0080\u009351.","DOI":"10.1073\/pnas.95.15.8847"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB54","doi-asserted-by":"crossref","unstructured":"54.\u00e2\u0080\u0082 Legoix P , Bluteau O , Bayer J , et al. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 1999; 18: 4044\u00e2\u0080\u00936.","DOI":"10.1038\/sj.onc.1202800"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB55","doi-asserted-by":"crossref","unstructured":"55.\u00e2\u0080\u0082 Wei Y , Fabre M , Branchereau S , et al. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2000; 19: 498\u00e2\u0080\u0093504.","DOI":"10.1038\/sj.onc.1203356"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB56","doi-asserted-by":"crossref","unstructured":"56.\u00e2\u0080\u0082 Davila JA , Petersena NJ , Nelson HA , El-Serag HB . Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol 2003; 56: 487\u00e2\u0080\u009393.","DOI":"10.1016\/S0895-4356(02)00605-4"},{"key":"10.1111\/j.1478-3231.2009.02126.x-BIB57","doi-asserted-by":"crossref","unstructured":"57.\u00e2\u0080\u0082 Darbari A , Sabin KM , Shapiro CN , Schwarz KB . Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003; 38: 560\u00e2\u0080\u00936.","DOI":"10.1053\/jhep.2003.50375"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.02126.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2009.02126.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:36:48Z","timestamp":1625665008000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.02126.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02126.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}